Multi‐modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models

ABSTRACT Preclinical research has demonstrated that nanoparticles and macromolecules can accumulate in solid tumors due to the enhanced permeability and retention effect. However, drug loaded nanoparticles often fail to show increased efficacy in clinical trials. A better understanding of how tumor heterogeneity affects nanoparticle accumulation could help elucidate this discrepancy and help in patient selection for nanomedicine therapy. Here we studied five human tumor models with varying morphology and evaluated the accumulation of 100nm polystyrene nanoparticles. Each tumor model was characterized in vivo using micro‐computed tomography, contrast‐enhanced ultrasound and diffusion‐weighted and dynamic contrast‐enhanced magnetic resonance imaging. Ex vivo, the tumors were sectioned for both fluorescence microscopy and histology. Nanoparticle uptake and distribution in the tumors were generally heterogeneous. Density of functional blood vessels measured by fluorescence microscopy correlated significantly (p=0.0056) with nanoparticle accumulation and interestingly, inflow of microbubbles measured with ultrasound also showed a moderate but significant (p=0.041) correlation with nanoparticle accumulation indicating that both amount of vessels and vessel morphology and perfusion predict nanoparticle accumulation. This indicates that blood vessel characterization using contrast‐enhanced ultrasound imaging or other methods could be valuable for patient stratification for treatment with nanomedicines.

[1]  O. Haraldseth,et al.  Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy , 2013, Angiogenesis.

[2]  Benjamin M Yeh,et al.  Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Ashley M. Laughney,et al.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle , 2015, Science Translational Medicine.

[4]  T. B. Pedersen,et al.  Assessment of early docetaxel response in an experimental model of human breast cancer using DCE‐MRI, ex vivo HR MAS, and in vivo 1H MRS , 2010, NMR in biomedicine.

[5]  D. Jaffray,et al.  Nanomedicine and tumor heterogeneity: Concept and complex reality , 2016 .

[6]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[7]  Amber L. Doiron,et al.  Nanoparticle accumulation in angiogenic tissues: towards predictable pharmacokinetics. , 2013, Small.

[8]  Brendan P. Flynn,et al.  Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[9]  F. Kiessling,et al.  Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Wenping Wang,et al.  Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound , 2015, Tumor Biology.

[11]  Michael Höpfner,et al.  The shunt problem: control of functional shunting in normal and tumour vasculature , 2010, Nature Reviews Cancer.

[12]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[13]  R. Korn,et al.  Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study , 2017, Clinical Cancer Research.

[14]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[15]  R K Jain,et al.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.

[16]  S. Barry,et al.  Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenografts. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Guido Gerig,et al.  3D Multi-scale line filter for segmentation and visualization of curvilinear structures in medical images , 1997, CVRMed.

[18]  D. Crommelin,et al.  Towards more effective advanced drug delivery systems. , 2013, International journal of pharmaceutics.

[19]  M. Versluis,et al.  Sonoprinting and the importance of microbubble loading for the ultrasound mediated cellular delivery of nanoparticles. , 2016, Biomaterials.

[20]  Jennifer I. Hare,et al.  Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.

[21]  B. Johansen,et al.  Anti‐angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro–computed tomography angiography and dynamic contrast enhanced MRI , 2016, Magnetic resonance in medicine.

[22]  D. Jaffray,et al.  Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Ick Chan Kwon,et al.  Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. , 2011, Biomaterials.

[24]  T. Iwanaga,et al.  Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. , 2001, Cancer research.

[25]  A. Padhani,et al.  Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.

[26]  Zahi A. Fayad,et al.  Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy , 2016, Nature Communications.

[27]  Ralph Weissleder,et al.  Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug , 2015, Nature Communications.

[28]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[29]  C. de Lange Davies,et al.  Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts , 2005, British Journal of Cancer.

[30]  G. Jensen,et al.  Conventional Liposome Performance and Evaluation: Lessons from the Development of Vescan , 2007, Journal of liposome research.

[31]  Andreas Kjær,et al.  Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes. , 2015, ACS nano.

[32]  Joseph W. Nichols,et al.  EPR: Evidence and fallacy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[33]  A. Giatromanolaki,et al.  Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[35]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[36]  Johannes E. Schindelin,et al.  The ImageJ ecosystem: An open platform for biomedical image analysis , 2015, Molecular reproduction and development.

[37]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[38]  E. Barbier,et al.  An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors , 2016, Scientific Reports.

[39]  M. Volm,et al.  Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. , 1996, British Journal of Cancer.

[40]  P. Stattin,et al.  Vascular density is a predictor of cancer‐specific survival in prostatic carcinoma , 1997, The Prostate.

[41]  Karen Campbell,et al.  64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer , 2017, Clinical Cancer Research.

[42]  Jan Grimm,et al.  Nanoparticles for imaging: top or flop? , 2014, Radiology.

[43]  R. Vile,et al.  Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  Fabian Kiessling,et al.  Micro-CT Imaging of Tumor Angiogenesis Quantitative Measures Describing Micromorphology and Vascularization , 2014 .

[45]  Kexiong Zhang,et al.  Impact of Tumor Vascularity on Responsiveness to Antiangiogenesis in a Prostate Cancer Stem Cell-Derived Tumor Model , 2013, Molecular Cancer Therapeutics.

[46]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[47]  Baris Turkbey,et al.  Imaging of tumor angiogenesis: functional or targeted? , 2009, AJR. American journal of roentgenology.

[48]  A. Brøgger,et al.  Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma , 1986, International journal of cancer.

[49]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[50]  N. Mitsakakis,et al.  Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Ming-Jium Shieh,et al.  Combining the single-walled carbon nanotubes with low voltage electrical stimulation to improve accumulation of nanomedicines in tumor for effective cancer therapy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[52]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[53]  Hege Wergedahl,et al.  Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI , 2007, Cancer biology & therapy.

[54]  G. Glover,et al.  Breast disease: dynamic spiral MR imaging. , 1998, Radiology.

[55]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.